Results 211 to 220 of about 146,798 (343)

The landscape of ketamine use disorder: Patient experiences and perspectives on current treatment options

open access: yesAddiction, EarlyView.
Abstract Aims To report the symptoms and aetiology of ketamine use disorder (KUD), gauge the effectiveness of current treatment services and identify strategies to enhance patient access and outcomes. Design Mixed‐methods, cross‐sectional questionnaire. Electronic survey from November 2023 to April 2024.
Rebecca E. Harding   +7 more
wiley   +1 more source

Ovarian Cancer G protein-coupled receptor-1 signaling bias dictates anti-contractile effect of benzodiazepines on airway smooth muscle. [PDF]

open access: yesRespir Res
Villalba DR   +10 more
europepmc   +1 more source

Ring Expansion Reaction of 4-Quinazolinones to 1,4-Benzodiazepines

open access: gold, 1974
Yoshihisa Yamada   +2 more
openalex   +1 more source

The γ‐aminobutyric‐acid/benzodiazepine‐receptor protein from rat brain [PDF]

open access: bronze, 1987
G.B. Stauber   +3 more
openalex   +1 more source

Effectiveness and safety of psychosocial interventions for the treatment of cannabis use disorder: A systematic review and meta‐analysis

open access: yesAddiction, EarlyView.
Abstract Aim To evaluate the effectiveness, safety and cost‐effectiveness of psychosocial interventions for cannabis use disorder (CUD). Methods A systematic review of randomized controlled trials (RCTs; PROSPERO protocol CRD42024553382) of psychosocial interventions for CUD lasting >4 sessions, delivered synchronously, to individuals with CUD aged ≥16
Monika Halicka   +11 more
wiley   +1 more source

Field-Portable Technology for Illicit Drug Discrimination via Deep Learning of Hybridized Reflectance/Fluorescence Spectroscopic Fingerprints. [PDF]

open access: yesAnal Chem
Power A   +19 more
europepmc   +1 more source

Extended‐release buprenorphine treatment for opioid use disorder: A mixed‐methods study of response and experience

open access: yesAddiction, EarlyView.
Abstract Background and aims An investigation of 24 weeks of extended‐release buprenorphine (BUP‐XR; Sublocade®) treatment for adults with opioid use disorder (OUD). Study aims were to characterise variations in clinical response, investigate personal factors influencing BUP‐XR experience and identify opportunities to tailor treatment interventions ...
Natalie Lowry   +13 more
wiley   +1 more source

Social cognition and decision‐making in people with methamphetamine use disorder

open access: yesAddiction, EarlyView.
Abstract Background and Aims Impairments in social cognition and social decision‐making play an important role in the disease burden experienced by individuals with methamphetamine use disorder (MUD). They are also assumed to play a role in the vicious cycle of MUD development and hinder its successful psychotherapy. However, research typically focuses
Justin Mahlberg   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy